Agilent and BPL Are Buying the Missing Pieces of the Stack

Device and diagnostics vendors are using M&A to fill workflow, software, and distribution gaps and build harder-to-displace platforms.

Updated

What is this trend?

Medical device and diagnostics companies are buying adjacent software, workflow, and distribution assets to own more of the full stack and make their platforms harder to replace.

  • Acquisitions are replacing partnerships as the fastest way to fill product and workflow gaps.
  • Regulatory-ready software and embedded clinical workflows are becoming core M&A targets.
  • Owning distribution, manufacturing, or interoperability can make hardware portfolios stickier.
  • The benchmark is stack completeness: vendors need end-to-end capability, not just a strong point product.

What’s the latest?

How it developed

  1. Orchestration, compliance, and utilization are reshaping medtech value, while interoperable stacks gain ground
    • Neurotherapy Competition Moves to Interoperable Workflow Stacks
  2. Subscription Care Stacks, Drone-Enabled Last-Mile Monitoring, and Interoperability as the New AID Moat
    • Interoperability Is Becoming the AID Competitive Moat
  3. Subscription CGM pull-through, tighter AI compliance, and imaging supply control reshape care delivery
    • Imaging Platforms Are Extending Into Supply, Manufacturing, and AI Workflow Control
  4. Reimbursement proof, AI compliance software, robotics distribution control, and stack consolidation
    • Agilent and BPL Are Buying the Missing Pieces of the Stack

Go deeper

Curated long-form picks on this trend — podcasts, videos, and analysis, by vantage.

Related trends

Stay ahead in Medical Devices & Tools

Get the weekly brief in your inbox — the developments, what they mean by vantage, and what to do next.